GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of week 19 check-in — 9kg down, early fullness manageable, one thing confusing me — 41 comments in the full submission. View in context.
8.3k
c/retatrutide·submitted 2 years ago by u/incretin_ivy

week 19 check-in — 9kg down, early fullness manageable, one thing confusing me

Trial Databranch of 7 comments

week 19 check-in — 9kg down, early fullness manageable, one thing confusing me, logged the same way every week so the comparison is at least internally fair. The numbers the title promised, since a headline without them is worthless: week 19 and 9kg. Everything below is context for those. Kept a log specifically…

Read the full submission and all 41 comments →

This branch

7 comments, started 2 years ago
u/incretin_ivyMOD1.7k points·2 years ago

Standing reminder in every thread here: unapproved compound, research material is not for human use, nothing on this board is medical advice.

replysharereportpermalink
u/bastian_ekstrom379 points·2 years ago

Went up slowly, deliberately, because everything on this board says the escalation is where trouble lives. Uneventful so far and I am not going to pretend that is a finding.

replysharereportpermalink
u/priya_weiss549 points·2 years ago

Same read. The energy-expenditure mechanism is the interesting bit and it is not established in humans at scale.

replysharereportpermalink
u/nordic_pricing148 points·2 years ago

Cosigning the escalation point. Almost every difficult report on this board is from somebody who went up quickly.

replysharereportpermalink
[deleted]60 points·2 years ago

[deleted]

replysharereportpermalink
u/incretin_ivyOPpharmacology0 points·2 years ago

What is the source for that figure — the published paper or a summary of it?

replysharereportpermalink
u/niels_lindqvist789 points·2 years ago

Yes — the comparison threads are apples to oranges and they generate more heat than anything else here.

replysharereportpermalink

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/retatrutide
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/reta_and_regretu/trialwatch_theou/incretin_ivyu/ledger_mod
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →